Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Colgate Announces 1st Quarter 2022 Results

 

Colgate-Palmolive Company (NYSE:CL):

  • Net sales increased 1.5%, Organic sales* increased 4.0%
  • On a GAAP basis, EPS declined 18% to $0.66; On a Base Business basis, EPS* declined 8% to $0.74
  • GAAP Gross profit margin and Base Business Gross profit margin* both decreased 220 basis points to 58.5%
  • Net cash provided by operations was $386 million for the first three months of 2022
  • Colgate’s leadership in toothpaste continued with its global market share at 39.2% year to date
  • Colgate’s leadership in manual toothbrushes continued with its global market share at 30.7% year to date
  • The Company updated its financial guidance for full year 2022
       
First Quarter Total Company Results (GAAP)      

($ in millions except per share amounts)

2022

2021

Change

Net Sales

$4,399

$4,344

+1.5%

EPS (diluted)

$0.66

$0.80

-18%

 

 

 

 

 

 

 

 

First Quarter Total Company Results (Base Business - Non-GAAP)*

     

($ in millions except per share amounts)

2022

2021

Change

Organic Sales Growth

 

 

+4.0%

Base Business EPS (diluted)

$0.74

$0.80

-8%

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 5 - Geographic Sales Analysis Percentage Changes” and “Table 6 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Colgate-Palmolive Company (NYSE:CL) today reported results for first quarter 2022. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business first quarter results, “We are pleased to have delivered another quarter of organic sales growth within our targeted range of 3% to 5%, despite a volatile operating environment worldwide. Net sales increased 1.5% and organic sales grew 4.0%, driven by higher pricing in nearly every region. Our investments in innovation and digital capabilities are paying off and should help us to continue our sales growth momentum.

“While our growth continued on the top line, our profitability was impacted by significant increases in raw material and logistics costs worldwide, and we expect the difficult cost environment to continue for the next several quarters. We remain sharply focused on our revenue growth management, including additional pricing, and funding-the-growth and other productivity initiatives. As we manage through this difficult time, we are committed to executing our plans with the right balance of pricing, productivity and brand support.

“As we look around the world, there is still much uncertainty stemming from the COVID-19 pandemic, supply chain disruptions, the war in Ukraine and volatility in consumer demand and currencies. Despite this environment, we are encouraged by our growth momentum, the strength of our innovation pipeline and the progress we are making on our digital transformation, all of which add to our confidence that we have the right strategies in place to continue to deliver sustainable, profitable growth over the long term.”

Full Year 2022 Guidance

Based on current spot rates:

  • The Company now expects net sales growth to be at the higher end of 1% to 4%, including a low-single-digit negative impact from foreign exchange.
  • The Company now expects organic sales growth to be within the range of 4% to 6%.
  • On a GAAP basis, the Company now expects a decline in gross profit margin, increased advertising investment and double-digit earnings-per-share growth.
  • On a non-GAAP (Base Business) basis, the Company now expects a decline in gross profit margin, increased advertising investment and a mid-single-digit earnings-per-share decline.

Divisional Performance

The following are comments about divisional performance for first quarter 2022 versus the year ago period. See attached "Table 5 - Geographic Sales Analysis Percentage Changes" and "Table 4 - Segment Information" for additional information on net sales and operating profit by division.

First Quarter Sales Growth By Division

(% change 1Q 2022 vs. 1Q 2021)

 

Net

Sales

Organic

Sales*

As Reported

Volume

Organic

Volume

Pricing

FX

North America

+0.5%

+0.5%

+1.5%

+1.5%

-1.0%

—%

Latin America

+5.5%

+6.5%

-3.5%

-3.5%

+10.0%

-1.0%

Europe

-9.0%

-3.0%

-5.0%

-5.0%

+2.0%

-6.0%

Asia Pacific

-1.5%

+1.0%

-3.5%

-3.5%

+4.5%

-2.5%

Africa/Eurasia

-2.0%

+7.5%

-6.5%

-6.5%

+14.0%

-9.5%

Hill's

+11.0%

+13.0%

+4.0%

+4.0%

+9.0%

-2.0%

 

 

 

 

 

 

 

Total Company

+1.5%

+4.0%

-1.5%

-1.5%

+5.5%

-2.5%

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 5 - Geographic Sales Analysis Percentage Changes” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

First Quarter Operating Profit By Division

($ in millions)

 

1Q 2022

% Change vs

1Q 2021

% to Net

Sales

Change in basis points

vs 1Q 2021

% to Net Sales

North America

$163

-19%

17.6%

-430

Latin America

$265

-3%

27.8%

-220

Europe

$150

-17%

22.9%

-220

Asia Pacific

$206

-8%

28.4%

-190

Africa/Eurasia

$44

-19%

16.5%

-340

Hill's

$204

-5%

23.4%

-400

 

 

 

 

 

Total Company, As Reported

$860

-14%

19.5%

-360

Total Company, Base Business*

$923

-8%

21.0%

-210

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

North America (21% of Company Sales)

  • Organic sales growth in oral care and personal care was partially offset by organic sales declines in home care.
  • In the United States, Colgate's share of the toothpaste market is 33.5% year to date and its share of the manual toothbrush market is 44.4% year to date.
  • The decrease in Operating profit as a percentage of Net sales was primarily due to significantly higher raw and packaging material costs and higher overhead expenses, driven by higher logistics costs, partially offset by cost savings from the Company’s funding-the-growth initiatives.

Latin America (21% of Company Sales)

  • Organic sales growth was led by Mexico, Argentina, Colombia and Brazil.
  • The decrease in Operating profit as a percentage of Net sales was primarily due to significantly higher raw and packaging material costs and higher logistics costs, partially offset by higher pricing, cost savings from the Company’s funding-the-growth initiatives, decreased advertising investment, overhead efficiencies and a value-added tax refund.

Europe (15% of Company Sales)

  • Organic sales declines in the Filorga duty-free business, France and Spain were partially offset by organic sales growth in Germany.
  • The decrease in Operating profit as a percentage of Net sales was primarily due to significantly higher raw and packaging material costs and higher overhead expenses, primarily driven by higher logistics costs, partially offset by cost savings from the Company’s funding-the-growth initiatives, decreased advertising investment and higher pricing.

Asia Pacific (17% of Company Sales)

  • Organic sales growth in Australia, the Philippines and Indonesia was partially offset by organic sales declines in the Greater China region and Thailand.
  • The decrease in Operating profit as a percentage of Net sales was primarily due to significantly higher raw and packaging material costs and higher logistics costs, partially offset by cost savings from the Company's funding-the-growth initiatives, higher pricing and overhead efficiencies.

Africa/Eurasia (6% of Company Sales)

  • Organic sales growth was led by Turkiye and South Africa.
  • The decrease in Operating profit as a percentage of Net sales was primarily due to significantly higher raw and packaging material costs, which included foreign exchange transaction costs, higher overhead expenses, primarily driven by higher logistics costs, and costs incurred due to the war in Ukraine, partially offset by higher pricing, decreased advertising investment and cost savings from the Company’s funding-the-growth initiatives.

Hill's Pet Nutrition (20% of Company Sales)

  • Organic sales growth was led by the United States and Europe.
  • The decrease in Operating profit as a percentage of Net sales was primarily due to significantly higher raw and packaging material costs and higher overhead expenses, primarily driven by higher logistics costs, partially offset by higher pricing, decreased advertising investment and cost savings from the Company’s funding-the-growth initiatives.

Prepared Management Remarks and Webcast Information

As a new practice, at approximately 7:00 a.m. ET today, Colgate will post its prepared management remarks (in PDF format) regarding first quarter results to the Investor Center section of its website at www.colgatepalmolive.com/investors.

At 8:30 a.m. ET today, Colgate will host a conference call regarding first quarter results. To access this call as a webcast, please go to Colgate’s website at www.colgatepalmolive.com.

About Colgate-Palmolive

Colgate-Palmolive Company is a caring, innovative growth company reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. We are recognized for our leadership and innovation in promoting sustainability and community wellbeing, including our achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children’s oral health through the Colgate Bright Smiles, Bright Futures program, which has reached more than 1.4 billion children since 1991. For more information about Colgate’s global business and how we are building a future to smile about, visit www.colgatepalmolive.com. CL-E

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In certain limited circumstances, the COVID-19 pandemic has impacted the ability of our third-party vendors to provide the Company with reliable updated market share data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This press release and the related webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, the impact of foreign exchange, the impact of COVID-19, the impact of the war in Ukraine, cost-reduction plans, including the 2022 Global Productivity Initiative, tax rates, new product introductions and digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases, or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 and subsequent Quarterly Reports on Form 10-Q). Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or on the Company’s website at www.colgatepalmolive.com.

Non-GAAP Financial Measures

The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and/or the related webcast, which may not be the same as or comparable to similar measures presented by other companies:

  • Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges relating to the 2022 Global Productivity Initiative.
  • Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.
  • Free cash flow before dividends: Net cash provided by operations less Capital expenditures.

This press release discusses Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three months ended March 31, 2022 versus 2021 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.

Worldwide Gross profit, Gross profit margin, Other (income) expense, net, Operating profit, Operating profit margin, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, gains and losses from certain acquisitions, divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See “Non-GAAP Reconciliations” for the three months ended March 31, 2022 and 2021 included with this release for a reconciliation of these financial measures to the related GAAP measures.

The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

As management uses free cash flow before dividends to evaluate the Company’s ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “Condensed Consolidated Statements of Cash Flows” for the three months ended March 31, 2022 and 2021 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

(See attached tables for first quarter results.)

 

 

 

Table 1

Colgate-Palmolive Company

 

Condensed Consolidated Statements of Income

 

For the Three Months Ended March 31, 2022 and 2021

 

(Dollars in Millions Except Per Share Amounts) (Unaudited)

 

 

 

2022

 

2021

 

 

 

 

 

Net sales

 

$

4,399

 

 

$

4,344

 

 

 

 

 

 

Cost of sales

 

 

1,827

 

 

 

1,707

 

 

 

 

 

 

Gross profit

 

 

2,572

 

 

 

2,637

 

 

 

 

 

 

Gross profit margin

 

 

58.5

%

 

 

60.7

%

 

 

 

 

 

Selling, general and administrative expenses

 

 

1,641

 

 

 

1,605

 

 

 

 

 

 

Other (income) expense, net

 

 

71

 

 

 

28

 

 

 

 

 

Operating profit

 

 

860

 

 

 

1,004

 

 

 

 

 

Operating profit margin

 

 

19.5

%

 

 

23.1

%

 

 

 

 

Non-service related postretirement costs

 

 

38

 

 

 

18

 

 

 

 

 

Interest (income) expense, net

 

 

27

 

 

 

29

 

 

 

 

 

Income before income taxes

 

 

795

 

 

 

957

 

 

 

 

 

 

Provision for income taxes

 

 

192

 

 

 

229

 

 

 

 

 

 

Effective tax rate

 

 

24.2

%

 

 

23.9

%

 

 

 

 

 

Net income including noncontrolling interests

 

 

603

 

 

 

728

 

 

 

 

 

 

Less: Net income attributable to noncontrolling interests

 

 

44

 

 

 

47

 

 

 

 

 

 

Net income attributable to Colgate-Palmolive Company

 

$

559

 

 

$

681

 

 

 

 

 

 

Earnings per common share

 

 

 

 

Basic

 

$

0.67

 

 

$

0.80

 

Diluted

 

$

0.66

 

 

$

0.80

 

 

 

 

 

 

Supplemental Income Statement Information

 

 

 

 

Average common shares outstanding

 

 

 

 

Basic

 

 

840.6

 

 

 

848.6

 

Diluted

 

 

843.7

 

 

 

851.4

 

 

 

 

 

 

Advertising

 

$

506

 

 

$

535

 

 

 

 

 

 

Table 2

Colgate-Palmolive Company

 

Condensed Consolidated Balance Sheets

 

As of March 31, 2022, December 31, 2021 and March 31, 2021

 

(Dollars in Millions) (Unaudited)

 

 

 

 

 

 

 

 

 

March 31,

2022

 

December 31,

2021

 

March 31,

2021

Cash and cash equivalents

 

$

877

 

 

$

832

 

 

$

995

 

Receivables, net

 

 

1,532

 

 

 

1,297

 

 

 

1,402

 

Inventories

 

 

1,924

 

 

 

1,692

 

 

 

1,676

 

Other current assets

 

 

656

 

 

 

576

 

 

 

490

 

Property, plant and equipment, net

 

 

3,752

 

 

 

3,730

 

 

 

3,609

 

Goodwill

 

 

3,292

 

 

 

3,284

 

 

 

3,701

 

Other intangible assets, net

 

 

2,415

 

 

 

2,462

 

 

 

2,787

 

Other assets

 

 

1,275

 

 

 

1,167

 

 

 

1,141

 

Total assets

 

$

15,723

 

 

$

15,040

 

 

$

15,801

 

 

 

 

 

 

 

 

Total debt

 

$

7,607

 

 

$

7,245

 

 

$

7,833

 

Other current liabilities

 

 

4,547

 

 

 

4,000

 

 

 

4,276

 

Other non-current liabilities

 

 

2,841

 

 

 

2,824

 

 

 

3,029

 

Total liabilities

 

 

14,995

 

 

 

14,069

 

 

 

15,138

 

Total Colgate-Palmolive Company shareholders’ equity

 

 

321

 

 

 

609

 

 

 

262

 

Noncontrolling interests

 

 

407

 

 

 

362

 

 

 

401

 

Total liabilities and equity

 

$

15,723

 

 

$

15,040

 

 

$

15,801

 

 

 

 

 

 

 

 

Supplemental Balance Sheet Information

 

 

 

 

 

 

Debt less cash, cash equivalents and marketable securities(1)

 

$

6,672

 

 

$

6,379

 

 

$

6,776

 

Working capital % of sales

 

 

(2.8

) %

 

 

(2.7

) %

 

 

(4.4

) %

Note:

(1) Marketable securities of $58, $34 and $62 as of March 31, 2022, December 31, 2021 and March 31, 2021, respectively, are included in Other current assets.

 

 

 

 

Table 3

Colgate-Palmolive Company

 

Condensed Consolidated Statements of Cash Flows

 

For the Three Months Ended March 31, 2022 and 2021

 

(Dollars in Millions) (Unaudited)

 

 

 

 

 

 

 

2022

 

2021

Operating Activities

 

 

 

 

Net income including noncontrolling interests

 

$

603

 

 

$

728

 

Adjustments to reconcile Net income including noncontrolling interests to Net cash provided by operations:

 

 

Depreciation and amortization

 

 

138

 

 

 

137

 

Restructuring and termination benefits, net of cash

 

 

81

 

 

 

(13

)

Stock-based compensation expense

 

 

29

 

 

 

38

 

Deferred income taxes

 

 

(7

)

 

 

6

 

Cash effects of changes in:

 

 

 

 

Receivables

 

 

(197

)

 

 

(170

)

Inventories

 

 

(215

)

 

 

(40

)

Accounts payable and other accruals

 

 

(28

)

 

 

(75

)

Other non-current assets and liabilities

 

 

(18

)

 

 

(13

)

Net cash provided by (used in) operations

 

 

386

 

 

 

598

 

 

 

 

 

 

Investing Activities

 

 

 

 

Capital expenditures

 

 

(122

)

 

 

(107

)

Purchases of marketable securities and investments

 

 

(36

)

 

 

(29

)

Proceeds from sale of marketable securities and investments

 

 

14

 

 

 

 

Other investing activities

 

 

3

 

 

 

(6

)

Net cash provided by (used in) investing activities

 

 

(141

)

 

 

(142

)

 

 

 

 

 

Financing Activities

 

 

 

 

Short-term borrowing (repayment) less than 90 days, net

 

 

413

 

 

 

365

 

Proceeds from issuance of debt

 

 

5

 

 

 

25

 

Dividends paid

 

 

(378

)

 

 

(376

)

Purchases of treasury shares

 

 

(410

)

 

 

(372

)

Proceeds from exercise of stock options

 

 

171

 

 

 

30

 

Other

 

 

(5

)

 

 

(6

)

Net cash provided by (used in) financing activities

 

 

(204

)

 

 

(334

)

 

 

 

 

 

Effect of exchange rate changes on Cash and cash equivalents

 

 

4

 

 

 

(15

)

Net increase (decrease) in Cash and cash equivalents

 

 

45

 

 

 

107

 

Cash and cash equivalents at beginning of the period

 

 

832

 

 

 

888

 

Cash and cash equivalents at end of the period

 

$

877

 

 

$

995

 

 

 

 

 

 

Supplemental Cash Flow Information

 

 

 

 

Free cash flow before dividends (Net cash provided by operations less Capital expenditures)

 

 

 

 

Net cash provided by operations

 

$

386

 

 

$

598

 

Less: Capital expenditures

 

 

(122

)

 

 

(107

)

Free cash flow before dividends

 

$

264

 

 

$

491

 

 

 

 

 

 

 

 

 

 

 

Income taxes paid

 

$

155

 

 

$

227

 

 

 

 

Table 4

Colgate-Palmolive Company

 

Segment Information

 

For the Three Months Ended March 31, 2022 and 2021

 

(Dollars in Millions) (Unaudited)

 

 

 

 

 

Three Months Ended March 31,

 

 

2022

 

2021

Net Sales

 

 

 

 

Oral, Personal and Home Care

 

 

 

 

 

 

 

 

 

North America

 

$

926

 

 

$

923

 

Latin America

 

 

954

 

 

 

907

 

Europe

 

 

654

 

 

 

717

 

Asia Pacific

 

 

726

 

 

 

739

 

Africa/Eurasia

 

 

267

 

 

 

272

 

 

 

 

 

 

Total Oral, Personal and Home Care

 

 

3,527

 

 

 

3,558

 

 

 

 

 

 

Pet Nutrition

 

 

872

 

 

 

786

 

 

 

 

 

 

Total Net Sales

 

$

4,399

 

 

$

4,344

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

 

2022

 

2021

Operating Profit

 

 

 

 

Oral, Personal and Home Care

 

 

 

 

 

 

 

 

 

North America

 

$

163

 

 

$

202

 

Latin America

 

 

265

 

 

 

272

 

Europe

 

 

150

 

 

 

180

 

Asia Pacific

 

 

206

 

 

 

224

 

Africa/Eurasia

 

 

44

 

 

 

54

 

 

 

 

 

 

Total Oral, Personal and Home Care

 

 

828

 

 

 

932

 

 

 

 

 

 

Pet Nutrition

 

 

204

 

 

 

215

 

Corporate(1)

 

 

(172

)

 

 

(143

)

 

 

 

 

 

Total Operating Profit

 

$

860

 

 

$

1,004

 

Note:

(1) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets.

Corporate Operating profit (loss) for the three months ended March 31, 2022 included charges resulting from the 2022 Global Productivity Initiative of $63.

Table 5

Colgate-Palmolive Company

 

Geographic Sales Analysis Percentage Changes

 

For the Three Months Ended March 31, 2022 vs. 2021

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COMPONENTS OF SALES CHANGE

 

 

 

 

 

 

 

 

 

 

 

 

 

Region

 

Sales

Change

As Reported

 

Organic

Sales Change

 

As Reported

Volume

 

Organic

Volume

 

Pricing

Coupons

Consumer &

Trade

Incentives

 

Foreign

Exchange

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Company

 

1.5

%

 

4.0

%

 

(1.5

) %

 

(1.5

) %

 

5.5

%

 

(2.5

) %

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

0.5

%

 

0.5

%

 

1.5

%

 

1.5

%

 

(1.0

) %

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Latin America

 

5.5

%

 

6.5

%

 

(3.5

) %

 

(3.5

) %

 

10.0

%

 

(1.0

) %

 

 

 

 

 

 

 

 

 

 

 

 

 

Europe

 

(9.0

) %

 

(3.0

) %

 

(5.0

) %

 

(5.0

) %

 

2.0

%

 

(6.0

) %

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia Pacific

 

(1.5

) %

 

1.0

%

 

(3.5

) %

 

(3.5

) %

 

4.5

%

 

(2.5

) %

 

 

 

 

 

 

 

 

 

 

 

 

 

Africa/Eurasia

 

(2.0

) %

 

7.5

%

 

(6.5

) %

 

(6.5

) %

 

14.0

%

 

(9.5

) %

 

 

 

 

 

 

 

 

 

 

 

 

 

Total CP Products

 

(1.0

) %

 

2.0

%

 

(2.5

) %

 

(2.5

) %

 

4.5

%

 

(3.0

) %

 

 

 

 

 

 

 

 

 

 

 

 

 

Hill’s

 

11.0

%

 

13.0

%

 

4.0

%

 

4.0

%

 

9.0

%

 

(2.0

) %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Emerging Markets(1)

 

1.5

%

 

4.5

%

 

(4.0

) %

 

(4.0

) %

 

8.5

%

 

(3.0

) %

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed Markets

 

1.0

%

 

3.5

%

 

0.5

%

 

0.5

%

 

3.0

%

 

(2.5

) %

Note:

(1) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

 

Table 6

Colgate-Palmolive Company

 

Non-GAAP Reconciliations

 

For the Three Months Ended March 31, 2022 and 2021

 

(Dollars in Millions Except Per Share Amounts) (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Other (Income) Expense, Net

 

 

 

 

 

2022

 

2021

 

 

Other (income) expense, net, GAAP

 

 

 

$

71

 

 

$

28

 

 

 

2022 Global Productivity Initiative

 

 

 

 

(63

)

 

 

 

 

 

Other (income) expense, net, non-GAAP

 

 

 

$

8

 

 

$

28

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Profit

 

 

 

 

 

2022

 

2021

 

% Change

Operating profit, GAAP

 

 

 

$

860

 

 

$

1,004

 

 

 

(14

) %

2022 Global Productivity Initiative

 

 

 

 

63

 

 

 

 

 

 

Operating profit, non-GAAP

 

 

 

$

923

 

 

$

1,004

 

 

 

(8

) %

 

 

 

 

 

 

 

 

 

 

 

 

Operating Profit Margin

 

 

 

 

 

2022

 

2021

 

Basis Point

Change

Operating profit margin, GAAP

 

 

 

 

19.5

%

 

 

23.1

%

 

 

(360

)

2022 Global Productivity Initiative

 

 

 

 

1.5

%

 

 

%

 

 

Operating profit margin, non-GAAP

 

 

 

 

21.0

%

 

 

23.1

%

 

 

(210

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-Service Related Postretirement Costs

 

 

 

2022

 

2021

 

 

Non-service related postretirement costs, GAAP

 

 

 

$

38

 

 

$

18

 

 

 

2022 Global Productivity Initiative

 

 

 

 

(19

)

 

 

 

 

 

Non-service related postretirement costs, non-GAAP

 

 

 

$

19

 

 

$

18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2022

 

Income Before

Income Taxes

 

Provision For

Income Taxes(1)

 

Net Income

Including

Noncontrolling

Interests

 

Net Income

Attributable To

Colgate-Palmolive

Company

 

Effective Income

Tax Rate(2)

 

Diluted Earnings

Per Share

As Reported GAAP

$

795

 

$

192

 

$

603

 

$

559

 

 

 

24.2

%

 

$

0.66

 

2022 Global Productivity Initiative

 

82

 

 

17

 

 

65

 

 

65

 

 

 

(0.4

) %

 

 

0.08

 

Non-GAAP

$

877

 

$

209

 

$

668

 

$

624

 

 

 

23.8

%

 

$

0.74

 

The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

Notes:

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

Contacts

John Faucher 212-310-3653

Hope Spiller 212-310-2291

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.